Complete Wegovy Dose Transition Guide From Mounjaro
Why Switch From Mounjaro to Wegovy: Complete Dose Availability
When switching to Wegovy from Mounjaro, having assured access to every dose throughout your treatment journey becomes crucial. EverydayMeds maintains comprehensive stock of all five Wegovy strengths, eliminating the common frustration of dose interruptions during critical escalation phases. Unlike single-dose suppliers, our complete range means you'll progress seamlessly from 0.25mg starter through to 2.4mg maintenance without changing pharmacy or facing supply gaps.
The transition from Mounjaro's tirzepatide dual-agonist mechanism to Wegovy's semaglutide GLP-1 approach requires careful dose management under prescriber guidance. Our clinical team understands that switching to Wegovy from Mounjaro often involves patients seeking different tolerability profiles or storage advantages, making uninterrupted dose progression essential for treatment success.
Wegovy Pricing Structure: Complete Cost Transparency
Switching to Wegovy from Mounjaro requires understanding the full cost journey across all dose levels. Single pen pricing starts at £79.99 for 0.25mg (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for maintenance 2.4mg doses. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these prices.
Our Getting Started bundles provide convenient dose progression: the Intro Duo (0.25mg & 0.5mg) costs £169.99 for weeks 1-8, whilst the Progress Trio (0.5mg, 1mg & 1.7mg) at £369.99 covers weeks 5-16. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring consistent long-term treatment without repeated ordering.
Clinical Evidence Supporting Wegovy Switch Decisions
The STEP clinical trial programme demonstrates Wegovy's efficacy when used alongside a reduced-calorie diet and increased physical activity. In STEP 1, participants achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 data showed sustained clinically studied weight loss maintained over two years of continuous treatment.
Recent SELECT cardiovascular outcomes data revealed a 20% reduction in major adverse cardiovascular events (HR 0.80) among patients with established cardiovascular disease. This evidence may influence prescriber decisions when switching to Wegovy from Mounjaro, particularly for patients with cardiovascular comorbidities requiring comprehensive risk management.
How Wegovy Mechanism Differs From Mounjaro
Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the natural incretin hormone released after eating. This mechanism reduces appetite by acting on brain appetite centres, promotes earlier satiety with smaller meal portions, and may reduce food cravings between meals. Unlike Mounjaro's dual GIP/GLP-1 approach, Wegovy focuses exclusively on GLP-1 pathways, which some patients find provides different tolerability profiles. The once-weekly FlexTouch injection system delivers consistent hormone levels throughout the seven-day dosing interval, supporting sustained appetite regulation throughout your treatment journey.
Streamlined Ordering Process for Wegovy Transition
Switching to Wegovy from Mounjaro through EverydayMeds begins with our three-minute online clinical assessment covering medical history, current medications, and treatment goals. Our prescribers review applications within three working days (24-hour express service available), ensuring appropriate dose selection for your transition. Once approved, next-day delivery arrives via temperature-controlled cold-chain logistics, maintaining the 2-8°C storage requirements. The prescription-only medicine arrives with comprehensive injection guidance, dose escalation timeline, and direct access to our clinical support team throughout your treatment.
Storage Advantages When Switching From Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, particularly valuable for frequent travellers or those with irregular schedules. Once removed from refrigeration, Wegovy pens remain stable at room temperature (below 30°C) for up to six weeks, significantly longer than Mounjaro's 21-day limit. The FlexTouch pen design provides consistent dose delivery with audible click confirmation, whilst the mandatory dose escalation schedule requires four-weekly increases from 0.25mg through 0.5mg, 1mg, 1.7mg, to final 2.4mg maintenance dosing. This extended room temperature stability eliminates travel concerns and provides greater lifestyle flexibility during your transition period.
Seamless Dose Escalation Journey Management
The key advantage of switching to Wegovy from Mounjaro through EverydayMeds lies in our assured dose continuity throughout the 17-week escalation period. Many patients experience supply disruptions when pharmacies stock only selected strengths, potentially compromising treatment efficacy or causing withdrawal symptoms. Our comprehensive inventory ensures smooth progression through each mandatory four-week phase, with automated reminders for next dose progression.
We provide detailed escalation calendars showing exactly when to advance doses, expected adjustment periods, and clinical support throughout your transition. This systematic approach eliminates the uncertainty often associated with switching to Wegovy from Mounjaro, providing confidence that your chosen pharmacy can support your complete treatment journey from initiation through maintenance phases.
Complete Treatment Support and Prescription Renewal
EverydayMeds provides lifetime treatment support for patients switching to Wegovy from Mounjaro, including automatic prescription renewal reminders and priority access to clinical consultations. Our GPhC-registered pharmacy (#9012878) maintains comprehensive treatment records, enabling seamless communication with your prescribing clinician about dose adjustments or side effect management. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our complete range from starter doses through maintenance supply. Visit https://everydaymeds.co.uk/collections/wegovy to begin your transition with confidence, knowing every dose remains available throughout your weight management journey alongside dietary modifications and increased physical activity.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
